Project Number AIA-19-604194 Agency/Funding Organization Alzheimer's Association Funding Year 2019 View Full Project Details for Developing HDAC6 inhibitors as novel therapeutics for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Kranz, Janice Principal Investigator First Name Janice Principal Investigator Last Name Kranz Awardee Organization Eikonizo Therapeutics, Inc. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2019: AIA RFA FY Overall Cost $150,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Murtishaw, Andrew asmurtishaw@alz.org
